Novoseven
- Generic Name: coagulation factor viia (recombinant)
- Brand Name: Novoseven
side effects drug center novoseven (coagulation factor viia (recombinant)) drug - patient side effects and images
Brand Names: NovoSeven RT, NovoSeven RT with MixPro
Generic Name: coagulation factor VIIa (injection)
- What is coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
- What are the possible side effects of coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
- What is the most important information I should know about coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
- What should I discuss with my healthcare provider before receiving coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
- How is coagulation factor VIIa given (NovoSeven RT, NovoSeven RT with MixPro)?
- What happens if I miss a dose (NovoSeven RT, NovoSeven RT with MixPro)?
- What happens if I overdose (NovoSeven RT, NovoSeven RT with MixPro)?
- What should I avoid after receiving coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
- What other drugs will affect coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
- Where can I get more information (NovoSeven RT, NovoSeven RT with MixPro)?
What is coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
Coagulation factor VIIa is a man-made protein similar to a natural protein in the body that helps the blood to clot.
Coagulation factor VIIa is used to treat or prevent bleeding in people with hemophilia A or hemophilia B, or factor VII deficiency.
Coagulation factor VIIa may also be used for purposes not listed in this medication guide.
What are the possible side effects of coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
- sudden numbness or weakness, especially on one side of the body;
- sudden severe headache, confusion, problems with vision, speech, or balance;
- chest pain, sudden cough, wheezing, rapid breathing, coughing up blood;
- pain, swelling, warmth, or redness in one or both legs;
- fever;
- little or no urinating;
- a feeling that you might pass out; or
- any bleeding that will not stop.
Common side effects may include:
- mild headache;
- joint pain;
- nausea, vomiting;
- swelling;
- mild itching or rash; or
- pain, redness, swelling, or irritation where the medicine was injected.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is the most important information I should know about coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
If possible before you receive coagulation factor VIIa, tell your doctor about all your medical conditions and allergies. Also make sure your doctor knows if you are pregnant or breast-feeding.
Call your doctor at once if you have sudden numbness or weakness, sudden cough or headache, pain or swelling in one or both legs, chest pain, or problems with vision, speech, or balance.
What should I discuss with my healthcare provider before receiving coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
You should not receive coagulation factor VIIa if you are allergic to it.
If possible before you receive coagulation factor VIIa, tell your doctor if you have:
- coronary artery disease (hardening of the arteries);
- a history of stroke or heart attack;
- a severe injury or infection;
- liver disease; or
- if you are allergic to mouse, hamster, or cow proteins.
In an emergency situation it may not be possible to tell your caregivers about your health conditions. Make sure any doctor caring for you afterward knows you have received this medicine.
It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant.
It is not known whether coagulation factor VIIa passes into breast milk or if it could harm a nursing baby. You should not breast-feed while receiving this medicine.
In an emergency situation it may not be possible to tell your caregivers if you are pregnant or breast feeding. Make sure any doctor caring for your pregnancy or your baby knows you have received this medication.
How is coagulation factor VIIa given (NovoSeven RT, NovoSeven RT with MixPro)?
Coagulation factor VIIa is injected into a vein through an IV. A healthcare provider will give you this injection.
You may need frequent medical tests to help your doctor determine how long to treat you with coagulation factor VIIa.
Wear a medical alert tag or carry an ID card stating that you have a bleeding disorder in case of emergency. Any medical care provider who treats you should know that you are using coagulation factor VIIa.
What happens if I miss a dose (NovoSeven RT, NovoSeven RT with MixPro)?
Because you will receive coagulation factor VIIa in a clinical setting, you are not likely to miss a dose.
What happens if I overdose (NovoSeven RT, NovoSeven RT with MixPro)?
Because you will receive coagulation factor VIIa in a clinical setting, you are not likely to miss a dose.
What should I avoid after receiving coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
What other drugs will affect coagulation factor VIIa (NovoSeven RT, NovoSeven RT with MixPro)?
Tell your doctor about all your current medicines and any you start or stop using, especially, medications to treat or prevent bleeding episodes, such as:
- anti-inhibitor coagulant complex; or
- factor IX complex.
This list is not complete. Other drugs may interact with coagulation factor VIIa, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.
Where can I get more information (NovoSeven RT, NovoSeven RT with MixPro)?
Your pharmacist can provide more information about coagulation factor VIIa.
Copyright 1996-2021 Cerner Multum, Inc.